We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Prevention of Biofilm Formation Renders Bacteria Susceptible to Macrophage Attack

By Biotechdaily staff writers
Posted on 17 Jul 2008
Microbiologists have used a recently patented antibiofilm enzyme to show that bacteria require both a leukotoxic agent and a surface polysaccharide to survive attack by immune system macrophages.

Biofilms are a major cause of a number of serious medical problems including chronic infections and medical device related infections. More...
They develop on surfaces such as catheters, prosthetic implants, teeth, lungs, and the urogenital tract. Biofilms are pervasive, costly to deal with, and approximately 80% of all human bacterial infections involve biofilms.

Investigators from the University of Medicine and Dentistry (Newark, NJ, USA) worked with monolayer cultures of the human macrophage cell line THP-1. The cultures were infected with either wild type cultures of the bacterium Aggregatibacter actinomycetemcomitans (A.a) or with A.a mutants lacking either leukotoxin, a secreted lipoprotein that kills human polymorphonuclear leukocytes and macrophages, or poly-N-acetylglucosamine (PGA), a surface polysaccharide that mediates intercellular adhesion, biofilm formation, and detergent resistance.

In some experiments the bacteria were treated with Kane Biotech, Inc's (Winnipeg, MB, CA) patented antibiofilm enzyme Dispersin B, which is capable of both inhibiting and dispersing bacterial biofilms.

Results published in the June 5, 2008, online edition of the journal Microbial Pathogenesis revealed that pretreatment of wild-type A.a cells with the PGA-hydrolyzing enzyme dispersin B rendered them sensitive to killing by THP-1 cells leading to the conclusion that both leukotoxin and PGA were necessary for evasion of macrophage killing by A.a.

"Our studies showed that the pretreatment of biofilm-embedded A.a cells with DispersinB removes the biofilm and renders the cells sensitive to killing by the body's macrophages,” said senior author Dr. Jeffery Kaplan, professor of oral biology at the University of Medicine and Dentistry.

"The findings of Dr. Kaplan's group suggest that when DispersinB is used in products such as wound gels and device coatings, either in combination with an antimicrobial or alone, it makes biofilm-embedded bacterial pathogens susceptible to killing by both antimicrobials and macrophages or by our body's macrophages alone,” said Dr. Sri Madhyastha, CSO of Kane Biotech.


Related Links:
University of Medicine and Dentistry
Kane Biotech

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Slide Scanner System
NanoZoomer S540MD
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.